NNNN.US Anbio Biotechnology Class A Ordinary Shares

Healthcare Biotechnology USA Stocks
3.88 USD
Close of Nov 17, 2026
3.09 44.73
Market cap
USD 170M
P/E
25.9x
P/B
5.68x
ROE
40.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is NNNN.US undervalued?

Graham number
Price3.88
Graham value1.52
Premium155.5%

NNNN.US trades 155.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Anbio Biotechnology Class A Ordinary Shares fundamental analysis

No fundamental analysis for Anbio Biotechnology Class A Ordinary Shares yet.

Anbio Biotechnology Class A Ordinary Shares stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care t…

Full company profile